Brovana® is a long-acting beta-2 adrenergic agonist (beta-2 agonist) indicated for treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), ... Jun 23
COPD is a progressive disease, which can cause obstruction of airflow in the lungs resulting in debilitating bouts of breathlessness and is the third leading ... Dec 14
Trixeo Aerosphere recommended for approval in the EU by CHMP for the maintenance treatment of COPD... Oct 19
-Advertisements-